Reata Lays Commercial Path For Skyclarys With First-Ever Friedreich’s Ataxia Nod

 
• By Alaric DeArment
  
The FDA approved Skyclarys, the first drug for Friedreich's ataxia • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip